1. Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial. Issue 2 (February 2021) Authors: Pignata, Sandro; Lorusso, Domenica; Joly, Florence; Gallo, Ciro; Colombo, Nicoletta; Sessa, Cristiana; Bamias, Aristotelis; Salutari, Vanda; Selle, Frédèric; Frezzini, Simona; De Giorgi, Ugo; Pautier, Patricia; Bologna, Alessandra; Orditura, Michele; Dubot, Coraline; Gadducci, Angiolo; Mammoliti,... Journal: Lancet oncology Issue: Volume 22:Issue 2(2021) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP1161 Exome analysis of vulvar and vaginal tumors reveals an antigen processing and presentation deficiency. (1st November 2019) Authors: Bengrine, L; Fumet, JD; Favier, L; Richard, C; Arnould, L; Boidot, R Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A602 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Self-management and adherence in childhood-onset systemic lupus erythematosus: what are we missing?. (April 2019) Authors: Harry, O; Crosby, L E; Smith, A W; Favier, L; Aljaberi, N; Ting, T V; Huggins, J L; Modi, A C Journal: Lupus Issue: Volume 28:Number 5(2019) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗